Xuanzhu Biopharm-B (02575.HK): Abnormal share price movement; preliminary discussions are underway with a certain party regarding a potential acquisition.

Zhito Finance APP news, Xuanzhu Biopharma-B (02575.HK) announced that the board of directors of the company has noted that the price of the company's H shares rose today. After making all reasonable inquiries regarding the company, the board of directors confirmed that it is not aware of any reason for the change, or any information that must be published to avoid a false market in the H shares, or any inside information that must be disclosed under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).